baht, decrease of 11.53 %. The reasons for the decrease are : 1.1 In the year 2019, Ramkhamhaeng Hospital Public Company Limited and its subsidiaries have the revenues from medical treatment of 3,746.88

months, end of March 31, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 Increase (decrease) Q1/2020 Q1/2019 Revenue from sales 45.46 67.47 (22.01 ) (32.62

2017 showing a decrease of Baht 60.75 million or representing 73.74 % decrease since there have been only 6 ongoing projects and no any additional awarded one. During this quarter, one project had been

investment properties (reverse) #DIV/0! EBIT 94.66 133.42 -29.05 63.92 70.64 -9.52 Share of gain (loss) from investment in joint ventures -8.45 -8.91 -5.16 Financial cost -62.62 -58.66 6.76 -50.57 -59.39

months, end of September 30, 2019 Financial Statement Consolidate financial statement % revenue from sales Q3/2019 Q3/2018 increase(decrease) Q3/2019 Q3/2018 Revenues from sales 159.78 140.51 19.27 13.71

months, end of September 30, 2019 Financial Statement Consolidate financial statement % revenue from sales Q3/2019 Q3/2018 increase(decrease) Q3/2019 Q3/2018 Revenues from sales 159.78 140.51 19.27 13.71

months, end of September 30, 2019 Financial Statement Consolidate financial statement % revenue from sales Q3/2019 Q3/2018 increase(decrease) Q3/2019 Q3/2018 Revenues from sales 159.78 140.51 19.27 13.71

ก.ล.ต. เปิดรับฟังความคิดเห็นหลักการแก้ไขหลักเกณฑ์การทำธุรกรรมการซื้อหรือขายหลักทรัพย์โดยมีสัญญาขายหรือซื้อคืน (repo/reverse repo)

stock a subsidiary and reverse allowance for doubtful accounts Page 2 of 3 investment in associated companies and reversal of impairment assets THB 15.57 million. 2. The cost of goods sold and services of

stock a subsidiary and reverse allowance for doubtful accounts Page 2 of 3 investment in associated companies and reversal of impairment assets THB 15.57 million. 2. The cost of goods sold and services of